AFFiRiS AG Release: Parkinson's Vaccine - Worldwide First Clinical Study in Vienna
6/5/2012 11:34:04 AM
More...
|
AFFiRiS AG Inverts into Human Capital - Chief Business Officer Recruited
12/5/2011 11:29:18 AM
More...
|
AFFiRiS AG: Capital Increase: AFFiRiS Brings Santo VC and MIG 11 on Board
11/8/2011 2:27:03 PM
More...
|
Capital Increase: AFFiRiS AG Brings Santo VC and MIG 11 on Board
11/8/2011 10:00:14 AM
More...
|
The Michael J. Fox Foundation Awards AFFiRiS AG $1.5 Million for the Clinical Development of the First Parkinson's Disease Vaccine
10/12/2011 10:15:51 AM
More...
|
AFFiRiS AG: Alzheimer's Vaccination Shows Promising Results
3/11/2011 9:31:31 AM
More...
|
AFFiRiS AG Announces an Extension of its Existing Alzheimer's Disease Vaccine Development Collaboration with GlaxoSmithKline (GSK) Triggering a Eur 3.5 Million Payment to Affiris
2/28/2011 10:56:45 AM
More...
|
The Michael J. Fox Foundation Funds AFFiRiS AG to Develop Parkinson's Vaccine
12/16/2010 10:20:59 AM
More...
|
AFFiRiS AG Alzheimer's Vaccine AD02 Already in Clinical Phase II
4/23/2010 10:09:52 AM
More...
|